ASIT Biotech is a clinical-stage biopharmaceutical company, which focuses on the research, development, and commercialization of immunotherapy products for the treatment of allergies. The Comany's products include gp-ASIT+ for the treatment of grass pollen allergy administered by subcutaneous injections; hdm-ASIT+ for the treatment of house dust mite allergy administered by subcutaneous injections; and food-ASIT+ for the treatment of peanut, cow's milk, and egg white allergies.
Market capitalization (19-Nov-2020)
Closing stock price (19-Nov-2020)
When was ASIT Biotech founded?
ASIT Biotech was founded in 1997.
Who are ASIT Biotech key executives?
ASIT Biotech's key executives are Michel Baijot, Yves Désiront and François Meurgey.
How many employees does ASIT Biotech have?
ASIT Biotech has 26 employees.
Who are ASIT Biotech competitors?
Competitors of ASIT Biotech include Creative Biolabs, KiOmed Pharma and Hoth Therapeutics.
Where is ASIT Biotech headquarters?
ASIT Biotech headquarters is located at Rue des Chasseurs Ardennais 7, Liège.
Where are ASIT Biotech offices?
ASIT Biotech has offices in Liège and Sint-Lambrechts-Woluwe.
How many offices does ASIT Biotech have?
ASIT Biotech has 2 offices.
Receive alerts for 300+ data fields across thousands of companies